These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 10848037

  • 1. Bilateral prophylactic mastectomy in women with an increased risk of breast cancer.
    Tecnologica MAP Suppl; 1999 Jun; ():3-6. PubMed ID: 10848037
    [No Abstract] [Full Text] [Related]

  • 2. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.
    Geiger AM, Yu O, Herrinton LJ, Barlow WE, Harris EL, Rolnick S, Barton MB, Elmore JG, Fletcher SW.
    Arch Intern Med; 2005 Mar 14; 165(5):516-20. PubMed ID: 15767526
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
    Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB.
    N Engl J Med; 1999 Jan 14; 340(2):77-84. PubMed ID: 9887158
    [Abstract] [Full Text] [Related]

  • 4. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
    Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL.
    J Clin Oncol; 2004 Mar 15; 22(6):1055-62. PubMed ID: 14981104
    [Abstract] [Full Text] [Related]

  • 5. Prophylactic bilateral mastectomy: patterns of practice.
    Metcalfe KA, Goel V, Lickley L, Semple J, Narod SA.
    Cancer; 2002 Jul 15; 95(2):236-42. PubMed ID: 12124821
    [Abstract] [Full Text] [Related]

  • 6. Magnetic resonance imaging of the breast for preoperative evaluation in patients with localized breast cancer.
    Tecnologica MAP Suppl; 2000 Sep 15; ():17-20. PubMed ID: 11511076
    [No Abstract] [Full Text] [Related]

  • 7. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, van den Ouweland AW, van Geel B, Klijn JG.
    J Clin Oncol; 2003 May 01; 21(9):1675-81. PubMed ID: 12721241
    [Abstract] [Full Text] [Related]

  • 8. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, Møller P, Weitzel J, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group.
    J Clin Oncol; 2008 Mar 01; 26(7):1093-7. PubMed ID: 18195327
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
    Clark K.
    J Insur Med; 1999 Mar 01; 31(1):41-3. PubMed ID: 10539391
    [No Abstract] [Full Text] [Related]

  • 10. Prophylactic mastectomy for prevention of breast cancer.
    Kuehl LM, Dobie S.
    J Fam Pract; 1999 Apr 01; 48(4):252-3. PubMed ID: 10229246
    [No Abstract] [Full Text] [Related]

  • 11. Magnetic resonance imaging of the breast for preoperative evaluation in patients with localized breast cancer.
    Technol Eval Cent Assess Program Exec Summ; 2004 Sep 01; 19(8):1-5. PubMed ID: 15724316
    [No Abstract] [Full Text] [Related]

  • 12. Total mastectomy: indications and techniques.
    Horton CE, Dascombe WH.
    Clin Plast Surg; 1988 Oct 01; 15(4):677-87. PubMed ID: 3224490
    [Abstract] [Full Text] [Related]

  • 13. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B.
    Cancer; 2006 Dec 15; 107(12):2745-51. PubMed ID: 17109443
    [Abstract] [Full Text] [Related]

  • 14. High-dose chemotherapy with autologous stem-cell support in the treatment of high-risk, primary breast cancer.
    Tecnologica MAP Suppl; 1999 Jan 15; ():8-10. PubMed ID: 10346740
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prophylactic mastectomy for BRCA1/2 carriers: progress and more questions.
    Hartmann LC, Degnim A, Schaid DJ.
    J Clin Oncol; 2004 Mar 15; 22(6):981-3. PubMed ID: 14981099
    [No Abstract] [Full Text] [Related]

  • 17. Prophylactic mastectomy.
    Zakaria S, Degnim AC.
    Surg Clin North Am; 2007 Apr 15; 87(2):317-31, viii. PubMed ID: 17498529
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Prophylactic mastectomies and immediate breast reconstruction in patients at very high genetic risk: our experience with 14 cases].
    Missana MC, Chompret A.
    Ann Chir Plast Esthet; 2008 Aug 15; 53(4):325-33. PubMed ID: 18055089
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.